Vector Blog

The hepatitis B vaccine is one of only three vaccines that are routinely given to newborns in the first days of life. But the current hepatitis B vaccine has limitations: multiple “booster” doses are needed, and it can’t be given to premature babies weighing less than 2 kg. Annette Scheid, MD, a neonatologist at Brigham...

Neuropathic pain is chronic pain originating through some malfunction of the nervous system, often triggered by an injury. It causes hypersensitivity to innocuous stimuli and is often extremely debilitating. It doesn’t respond to existing painkillers — even opioids can’t reach it well. New research in a mouse model, described last week in Cell Reports, deconstructed...

News and Events

From the Research Lab to the Marketplace: Intellectual Property Basics for Boston Children’s Hospital
Join attorneys from Wolf Greenfield to learn the fundamentals of IP and discuss best practices for transferring your research from the lab to the marketplace.

The Boston Children’s Technology Development Fund is pleased to launch its 10th funding cycle on January 16, 2018!
Letters of Intent (LOI) are due to Technology.Development@childrens.harvard.edu on Feb. 12, 2018.

TIDO is proud to announce the release of our new Inventor’s Guide. The booklet details the commercialization process at Boston Children’s, how to work with TIDO to give your invention the best possibility for success, and answers to frequently asked questions we encounter.